Background. Fractures are common in individuals with chronic kidney disease (CKD), and tests of neuromuscular function (NMT) discriminate well among fractured and non-fractured patients with Stage 5 CKD on dialysis. The ability of NMT to discriminate fracture status in patients with Stages 3-5 CKD is unknown. Methods. In this cross-sectional study, we sought to determine in adult patients with Stages 3-5 CKD (eGFR by the Modification of Diet in Renal Disease equation) if NMT [timed up and go (TUG), 6-min walk (6MW) and grip strength] could discriminate fracture status (self-reported low-trauma fractures since age 40 and/or vertebral fractures by morphometry). We conducted logistic regression and receiver-operating characteristic (ROC) curves for each predictor [expressed as area under the ROC curves (AUROC) with 95% confidence intervals (CI)]. Results. Data was available for 125 men and 86 women. The mean age was 63.3 6 15.5 years, duration of CKD was 96.7 6 125.3 months and one-third had diabetes. Patients with fractures were older and fell more frequently (P < 0.05). After adjusting for age, weight and sex, for every standard deviation increase in TUG and 6MW, the risk of fracture increased [odds ratio (OR): 1.68; 95% CI: 1.40-2.02] and decreased (OR: 0.53; 95% CI: 0.52-0.54), respectively. Both the TUG and 6MW could discriminate among those with and without fractures (AUROC: 0.90; 95% CI:0.84-0.95, AUROC: 0.87; 95% CI: 0.80-0.94, respectively). Conclusions. The TUG and 6MW are able to discriminate fracture status in patients with Stages 3-5 CKD. These tests do not require specialized expertise/equipment and are an inexpensive method to assess for the presence of fractures.
Introduction
Bone loss occurs early in chronic kidney disease (CKD). It is associated with an increased risk of fracture and as high as 50% of patients with CKD will have sustained a fracture prior to initiating dialysis [1] [2] [3] . Identifying patients at high fracture risk and targeting treatments to this group, whether pharmaceutical or other treatments, is a potential strategy to decrease fracture burden. Traditionally, studies on fracture risk assessment have focused on bone mass measurements. However, declining renal function is associated with decreases in functional ability, poor energy and malnutrition [4, 5] , all of which might increase fracture risk. Tests of neuromuscular function (NMT), such as the timed up and go test (TUG) and the 6-min walk test (6MW), have been shown to discriminate among patients with and without fractures on dialysis [6] . It is unknown whether the TUG and 6MW are able to discriminate fracture status among patients with CKD not yet on dialysis.
The purpose of our study was to determine if NMT, specifically, the TUG, the 6MW and hand grip strength, were able to discriminate among those patients with Stages 3-5 CKD with and without fractures. We hypothesized that the TUG and 6MW, which are more general assessments of neuromuscular function, but not grip strength, would be able to discriminate fracture status.
Materials and methods

Study participants
We enrolled 211 patients over 30 months from three CKD clinics in Toronto, Ontario, Canada. These tertiary care clinics provide multidisciplinary kidney specific care and education to Stages 3-5 CKD patients.
Patients !18 years of age with an estimated glomerular filtration rate (eGFR) <60 mL/min as calculated by the Modification of Diet in Renal Disease (MDRD) short formula [7] and not receiving renal replacement therapy were enrolled. We excluded patients with prior renal transplants, those taking bisphosphonate therapy or calcitonin, and women taking hormone replacement therapy or the oral contraceptive pill. All study testing, including the TUG, 6MW, grip strength, bone mineral density (BMD) by dual X-ray absorptiometry at the ultradistal radius, blood sampling and spine radiographs were performed at the Toronto General Hospital, Toronto, Ontario. Neuromuscular testing, BMD, radiographs and laboratory testing were usually assessed on the same day. When blood draws and NMT did not occur on the same day, we included laboratory values that were obtained within 30 days of the NMT date. All participants gave written informed consent, and the appropriate institutional review boards approved the study.
Interviewer-administered questionnaire
Patients were interviewed by a research co-ordinator to determine date of birth, race, current alcohol consumption, current caffeine consumption, current smoking status, physical activity habits and family history of osteoporosis (fractures in a first-degree relative). We inquired about fractures, falls in the past 12 months, the presence of diabetes and self-reported duration and cause of CKD. The questionnaire has been used in several populations, including patients with Stage 5 CKD [1, 8] .
Outcome
The primary outcome was the presence of low-trauma fractures. Three classifications for fractures were defined: (i) history of low-trauma fractures since age 40 years old, (ii) prevalent vertebral fractures identified by spinal radiographs and (iii) either of the first two classifications.
Low-trauma fractures by history
We inquired about fractures since age 40 and classified fractures as lowtrauma or traumatic according to the World Health Organization definition [9] . Only low-trauma fractures defined as fractures that occur from minimal trauma, such as a fall from a standing height or less, were included in our analyses. We confirmed all self-reported low-trauma fractures by independent expert radiologic review.
Quantitative morphometry
All patients had anteroposterior and lateral radiographs of the thoracic and lumbar spine to identify prevalent fractures. A prevalent fracture was defined as a decrease in vertebral height of at least 20% and !4 mm in any vertical dimension compared with the vertebra above or below one or more thoracic and lumbar vertebrae [10] . Films were interpreted by a single experienced radiologist who was blinded to the clinical history and results of neuromuscular testing.
Neuromuscular testing
We performed three tests of neuromuscular function: the TUG [11, 12] , the 6MW [13] and hand grip strength [14] . The 6MW was only performed if the patient was able to do the TUG in <20 s. These tests determine muscle strength and balance across a wide range of functional abilities and have been validated in populations with kidney disease [6] .
The TUG involves the patient rising from a supported seated position (hands crossed over chest), walking 3 m, turning around and returning to the initial seated position. The result was the time taken to perform this task in seconds, measured by a stopwatch [11, 12] . For the 6MW, patients were instructed to walk as far as possible (distance) in 6 min. The total distance walked was measured and any rests taken were noted [13] . Lastly, hand grip strength was assessed with the patient seated with their elbow at 90°, forearm pronated and wrist in neutral position. The Jamar hand grip dynamometer measures the patient's grip strength (in kilograms). The mean of three trials was recorded [14] . We measured grip strength in both hands of all patients and noted hand dominance. We report the mean of the dominant hand. Those with fractures of the dominant hand were excluded from analysis. These NMT were conducted under the instruction of a trained research assistant blinded to our study hypotheses and followed a standardized protocol.
Statistical analyses
Descriptive statistics (t-test, chi-squared or Fishers exact test, as appropriate) were used to determine univariate associations between fractures and demographic and lifestyle factors, comorbidities, etiology and duration of CKD and serum markers of mineral metabolism, including calcium, phosphate, parathyroid hormone and 25(OH) vitamin D.
We used logistic regression to examine the relationships between fractures and neuromuscular testing (the TUG and 6MW). Each predictor was analyzed as a continuous variable and adjusted for age, weight and sex. We also performed additional analyses adjusted for age, weight, sex, history of falls and BMD by dual X-ray absorptiometry at the ultradistal radius. Results are expressed as the odds ratio (OR) of fracture per standard deviation increase in the predictor.
To examine the discriminative ability of these tests for fracture, receiver-operating characteristic (ROC) curves were constructed for each predictor variable. The area under the ROC curves (AUROC) for the TUG and 6MW using a chi-squared test was compared [15, 16] . Analyses were performed with STATA Version 11.0 (STATA Corporation, College Station, TX). Statistical tests were considered significant at a two-tailed level of 0.05 and were not adjusted for multiple comparisons.
Results
We identified 432 eligible patients by chart review. Of these patients, 221 did not wish to participate (the most common reasons being that they were 'too busy' or had difficulty obtaining transportation) leaving 211 participants. Of the 221 who declined, 200 (90%) allowed us to conduct a chart review to compare demographic characteristics of nonparticipants and participants. Non-participants were more often women (120 of 200; 60%) compared to those who agreed to participate (86 of 211; 40%; P < 0.001), but there were no other significant differences.
Most participants were Caucasian men ( Table 1 ). The mean age was 63.3 AE 15.5 years, the mean duration of CKD was 96.7 AE 125.3 months and roughly one in three participants had CKD due to diabetic nephropathy. The patients' eGFRs at study entry were equally divided between CKD Stages 3-5. There were 77 fractures in 74 patients; 41 patients had prevalent spine fractures; 36 had self-reported low-trauma fractures (15 wrist, 5 rib, 3 humerus, 2 clinical spine, 2 hip, 1 clavicle, 1 sacrum, 1 pelvis, 6 ankle) and 3 patients had both a prevalent spine fracture and reported a low-trauma fracture. Of the 15 patients with a wrist fracture, 8 completed NMT and of these 8 patients, 2 of them reported fractures of the dominant wrist and were excluded from our analysis of grip strength.
Patients with fractures were found to be of older age (P ¼ 0.03), lighter weight (P ¼ 0.05), had a higher level of serum parathyroid hormone (mean for fracture 39.7 AE 35.7 pmol/L versus non-fracture 22.0 AE 28.3 pmol/L, normal range 1.6-6.9 pmol/L; P ¼ 0.002) and reported falling more frequently in the past year (P < 0.001). Serum phosphate (normal range: 0.8-1.35 mmol/L), and serum calcium (normal range: 2.20-2.62 mmol/L) were within normal limits for both fracture and non-fracture patients with CKD. However, 25(OH) vitamin D was in the sub-optimal range (25-75 nmol/L) for both groups. Patients with Stage 3 CKD were less likely to have a fracture compared with those with Stages 4 and 5 CKD (P < 0.0001 for all comparisons).
Of the 211 patients, 132 completed NMT. Of the 132 patients who completed the TUG, only one was unable to complete the TUG in <20 s; 131 patients performed the 6MW. The TUG was increased and the distance walked in 6 min was reduced in patients who had fractures compared to those without fractures (P < 0.0001 for both comparisons) ( Table 2 ). In contrast, we did not find a difference in hand grip strength by fracture status (P ¼ 0.104). When we examined the tests by stage of CKD, patients with fractures had inferior performance compared to patients without fractures (P < 0.0001 for all comparisons). Results were similar regardless of whether we considered prevalent vertebral fractures and self-reported fractures separately (data not shown).
After adjusting for age, weight and sex, we found that for every standard deviation increase in the TUG the risk of fracture (self reported and/or prevalent vertebral fracture) increased [OR: 1.68; 95% confidence interval (CI): 1.40-2.02)]. For every standard deviation increase in the 6MW, the odds of fracture decreased (OR ¼ 0.53; 95% CI: 0.52-0.54). Further adjustments for falls and BMD at the ultradistal radius did not significantly change the fracture risk for either the TUG or 6MW (Table 3 ). ROC curves confirmed that both the TUG and the 6MW were able to discriminate among those with and without fractures. After adjusting for age, weight and sex, the AUROC for the TUG was 0.90 (95% CI: 0.84-0.95) and the AUROC for the 6MW was 0.87 (95% CI: 0.80-0.94) (Figure 1 ). These curves were not significantly different (P ¼ 0.46). Additional adjustments for falls and BMD at the ultradistal radius did not change the AUROC for the TUG, while there was a modest improvement in the AUROC for the 6MW (P ¼ 0.03 for comparison of 6MW AUROC adjusted for age, weight and sex, versus age, weight, sex, falls and BMD at the ultradistal radius) ( Table 3) . Results were similar when we considered prevalent vertebral fractures and self-reported fractures separately (data not shown).
Discussion
The main finding of this study is that NMT, specifically, the TUG and the 6MW tests can discriminate fracture status well among patients with Stages 3-5 CKD. Of note, we did not find an association between grip strength and fracture status. This may be due to the fact that grip strength evaluates only muscle strength in the hand, and unlike the TUG and 6MW, does not reflect balance, co-ordination and large muscle strength; these factors influence musculoskeletal health and therefore, fracture risk.
Only one other study reported on associations between decreased kidney function (estimated creatinine clearance by Cockcroft-Gault <65 mL/min) and each of falls, NMT and fractures [17] . Dukas et al. [17] found that among those with decreased kidney function there was a higher prevalence of fractures and falls and a worse performance on NMT (TUG, tandem standing test and chair rising test); however, the discriminative ability of neuromuscular testing to identify those with falls or fractures was not examined.
Our results are consistent with findings from our previously published cross-sectional study in patients with endstage renal disease on hemodialysis [6] . In that study, we reported that a quicker TUG (OR per SD decrease: 0.14; 95% CI: 0.11-0.23) and greater distance walked in 6 min a Fracture defined as self-reported low-trauma fracture since age 40 and/or prevalent vertebral fracture by morphometry at study entry. (OR per SD increase: 0.10; 95% CI: 0.03-0.36) were associated with a reduced risk of fracture and the AUROCs were similar for both NMT [6] . Not surprisingly, patients in our study performed worse with regards to the TUG and the 6MW compared to healthy, community dwelling older adults between the ages of 60-80 years (13 versus 8.5 s for the TUG and 368 versus 527 meters for the 6MW, respectively) [18] . The decrease in functional capacity found among patients with CKD may be due to a variety of factors, including concomitant cardiovascular disease, poor nutrition, myopathy and neuropathy [4, 5] . All of these factors have been found to worsen with declining renal function.
In our population, we did not find that severity of CKD played a role in the impairment of neuromuscular function. Possible explanations for this include not only our small sample size but the fact that cut points for stages of CKD are arbitrary [19] -patients with an eGFR of 30 mL/min (Stage 3 CKD) may or may not be different than patients with an eGFR of 27 mL/min (Stage 4 CKD). As such, eGFR might be best thought of as having a continuous gradient of risk, analogous to blood pressure where higher blood pressure means higher risk of stroke. Exploring eGFR as a continuous gradient of risk is a future direction of our research program.
This study has some limitations. Due to its cross-sectional nature, we currently cannot explain the exact reasons for the increased prevalence of fractures associated with reduced neuromuscular function. For example, the TUG and the 6MW may not reflect habitual daily activity habits or physical activity levels, both of which can contribute to fracture risk. Also, over half of our patients walked 2 h a week, and most had normal levels of serum calcium, phosphate and vitamin D levels in the sufficient range, and as such, our findings may not be generalizable to those who are less active or have abnormalities in markers of mineral metabolism. We did not collect data on use of vitamin D metabolites. Of note, most patients have baseline blood work drawn to determine their vitamin D levels when they enter the multidisciplinary renal clinics and are supplemented with vitamin D accordingly. However, even in those patients who did not receive vitamin D, it is unlikely that the use of vitamin D metabolites confounded the association between NMT and fractures in our study. The data is conflicting as to whether vitamin D supplementation decreases fractures in patients without CKD (there are no randomized trials examining fracture reduction with vitamin D supplementation in patients with CKD) and data from the Women's Health Initiative suggests that vitamin D supplementation does not prevent decline in physical function [20, 21] . Currently, we are unable to determine the ability of the TUG and 6MW to predict the risk of future fractures but this is an area of active research by our group.
The tests of neuromuscular function measured in this study, the TUG and 6MW, have easy applicability. They do not require specialized expertise, equipment or space and can be performed efficiently in a clinical setting. As such, they are a relatively inexpensive and practical method to assess for the presence of fractures in clinical practice.
In summary, the TUG and 6MW are easily applied neuromuscular tests that have excellent discriminative ability to detect fractures in patients with Stages 3-5 CKD. Further prospective studies are required to evaluate their predictive ability for future fractures and how interventions aimed at improving neuromuscular function may impact fracture risk. Adjusted for age, weight, sex, falls and BMD at the ultradistal radius. Fig. 1 . Relationship between sensitivity and specificity of the 6MW and the TUG and the ability to identify patients with fracture (Fracture defined as selfreported low-trauma fracture since age 40 and/or prevalent vertebral fracture by morphometry at study entry). The area under the receiver operating characteristic curve for the 6MW was 0.87 and for TUG was 0.90 (P > 0.05).
